Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Feb;68(2):215–224. doi: 10.1111/j.1476-5381.1980.tb10410.x

Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature

Eira Apperley, W Feniuk, PPA Humphrey, GP Levy
PMCID: PMC2043926  PMID: 7357206

Abstract

1 As part of an investigation into the mode of action of anti-migraine drugs, a study of the excitatory receptors for 5-hydroxytryptamine (5-HT) has been carried out in a range of isolated vascular preparations from the dog.

2 5-HT contracted the dog isolated femoral artery and saphenous vein over the concentration-range 1.0 × 10-8 to 5.0 × 10-6 mol/l.

3 In the femoral artery methysergide and cyproheptadine were potent, competitive and specific antagonists of the contractile responses to 5-HT, with pA2 values of 8.52 and 8.55 respectively.

4 In the saphenous vein, methysergide was only a weak antagonist of 5-HT. In addition, it was an agonist over the concentration-range 5.0 × 10-8 to 1.0 × 10-5 mol/l. Cyproheptadine was a weak and unsurmountable antagonist of contractile responses to 5-HT and methysergide.

5 Contractile responses to 5-HT and methysergide in the saphenous vein were not antagonized by morphine (3.0 × 10-5 mol/l), indomethacin (5.0 × 10-5 mol/l), phentolamine (5.0 × 10-7 mol/l), propranolol (1.0 × 10-6 mol/l), atropine (1.0 × 10-6 mol/l), mepyramine (1.0 × 10-6 mol/l) or cimetidine (1.0 × 10-5 mol/l).

6 In the external carotid and lingual arteries the pattern of activity obtained with methysergide and cyproheptadine was the same as that in the femoral artery, while in the auricular artery the pattern of activity was the same as that in the saphenous vein.

7 The results are consistent with the hypothesis that there are two types of receptor mediating 5-HT-induced vasoconstriction in dog vasculature. One type, characterized by the pattern of activity obtained in the femoral artery, is like the previously described `D-receptor'. The other type, characterized by the pattern of activity obtained in the saphenous vein, has not been described before. The verification of this hypothesis requires the identification of a specific antagonist of 5-HT and methysergide in the saphenous vein.

Full text

PDF
215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apperley E., Humphrey P. P., Levy G. P. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol. 1976 Oct;58(2):211–221. doi: 10.1111/j.1476-5381.1976.tb10398.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Apperley E., Humphrey P. P., Levy G. P. Two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature? [proceedings]. Br J Pharmacol. 1977 Nov;61(3):465P–465P. [PMC free article] [PubMed] [Google Scholar]
  3. Bakhle Y. S., Smith T. W. Tryptamine receptors in rat pulmonary artery. Br J Pharmacol. 1974 Jul;51(3):459–461. doi: 10.1111/j.1476-5381.1974.tb10684.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bartlet A. L., Hassan T. Some actions of histamine and 5-hydroxytryptamine on isolated chicken oesophagus. Br J Pharmacol Chemother. 1968 Jan;32(1):156–163. doi: 10.1111/j.1476-5381.1968.tb00439.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brandão F. A comparative study of the role played by some inactivation pathways in the disposition of the transmitter in the rabbit aorta and the saphenous vein of the dog. Blood Vessels. 1976;13(5):309–318. doi: 10.1159/000158100. [DOI] [PubMed] [Google Scholar]
  6. DAY M., VANE J. R. An analysis of the direct and indirect actions of drugs on the isolated guinea-pig ileum. Br J Pharmacol Chemother. 1963 Feb;20:150–170. doi: 10.1111/j.1476-5381.1963.tb01306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drakontides A. B., Gershon M. D. 5-hydroxytryptamine receptors in the mouse duodenum. Br J Pharmacol Chemother. 1968 Jul;33(3):480–492. doi: 10.1111/j.1476-5381.1968.tb00496.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FANCHAMPS A., DOEPFNER W., WEIDMANN H., CERLETTI A. [Pharmacological characterization of deseril, a serotonin antagonist]. Schweiz Med Wochenschr. 1960 Sep 10;90:1040–1046. [PubMed] [Google Scholar]
  9. FURCHGOTT R. F., BHADRAKOM S. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther. 1953 Jun;108(2):129–143. [PubMed] [Google Scholar]
  10. Feniuk W., Humphrey P. P., Levy G. P. Further evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog vasculature [proceedings]. Br J Pharmacol. 1977 Nov;61(3):466P–466P. [PMC free article] [PubMed] [Google Scholar]
  11. Feniuk W., Humphrey P. P., Watts A. D. Evidence for a presynaptic inhibitory receptor for 5-hydroxytryptamine in dog isolated saphenous vein [proceedings]. Br J Pharmacol. 1978 Jun;63(2):344P–345P. [PMC free article] [PubMed] [Google Scholar]
  12. Fozard J. R., Ali A. T. Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. Naunyn Schmiedebergs Arch Pharmacol. 1978 Jan-Feb;301(3):223–235. doi: 10.1007/BF00507041. [DOI] [PubMed] [Google Scholar]
  13. Fozard J. R. Comparative effects of four migraine prophylactic drugs on an isolated extracranial artery. Eur J Pharmacol. 1976 Mar;36(1):127–139. doi: 10.1016/0014-2999(76)90264-8. [DOI] [PubMed] [Google Scholar]
  14. Fozard J. R., Mobarok ALI A. T. Blockade of neuronal tryptamine receptors by metoclopramide. Eur J Pharmacol. 1978 May 1;49(1):109–112. doi: 10.1016/0014-2999(78)90228-5. [DOI] [PubMed] [Google Scholar]
  15. GADDUM J. H., PICARELLI Z. P. Two kinds of tryptamine receptor. Br J Pharmacol Chemother. 1957 Sep;12(3):323–328. doi: 10.1111/j.1476-5381.1957.tb00142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. GADDUM J. H. Theories of drug antagonism. Pharmacol Rev. 1957 Jun;9(2):211–218. [PubMed] [Google Scholar]
  17. Gagnon D. J. Contraction of the rat colon by sympathomimetic amines: effect of methysergide and 5-HT desensitization. Eur J Pharmacol. 1972 Mar;17(3):319–324. doi: 10.1016/0014-2999(72)90111-2. [DOI] [PubMed] [Google Scholar]
  18. Görlitz B. D., Frey H. H. Letter: Comparison of the blocking effects of antagonists of adrenaline and 5-hydroxytryptamine on their mutual receptors. J Pharm Pharmacol. 1973 Aug;25(8):651–653. doi: 10.1111/j.2042-7158.1973.tb10654.x. [DOI] [PubMed] [Google Scholar]
  19. Humphrey P. P. The effects of alpha-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein. Br J Pharmacol. 1978 Aug;63(4):671–675. doi: 10.1111/j.1476-5381.1978.tb17281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jalfre M., Ruch-Monachon M. A., Haefely W. Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain. Adv Biochem Psychopharmacol. 1974;10:121–134. [PubMed] [Google Scholar]
  21. Kohli J. D. Receptors for sympathomimetic amines in the rabbit aorta: differentiation by specific antagonists. Br J Pharmacol Chemother. 1968 Feb;32(2):273–279. doi: 10.1111/j.1476-5381.1968.tb00971.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mawson C., Whittington H. Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol. 1970 May;39(1):223P–224P. [PMC free article] [PubMed] [Google Scholar]
  23. SICUTERI F. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine. Int Arch Allergy Appl Immunol. 1959;15:300–307. doi: 10.1159/000229055. [DOI] [PubMed] [Google Scholar]
  24. Saxena P. R. Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol. 1974 Jun;27(1):99–105. doi: 10.1016/0014-2999(74)90206-4. [DOI] [PubMed] [Google Scholar]
  25. Saxena P. R. The effects of antimigraine drugs on the vascular responses by-5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action. Headache. 1972 Jul;12(2):44–54. doi: 10.1111/j.1526-4610.1972.hed1202044.x. [DOI] [PubMed] [Google Scholar]
  26. Saxena P. R., van Houwelingen P., Bonta I. L. The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Eur J Pharmacol. 1971;13(3):295–305. doi: 10.1016/0014-2999(71)90218-4. [DOI] [PubMed] [Google Scholar]
  27. Vargaftig B. B., Lefort J. Pharmacological evidence for a vasodilator receptor to serotonin in the nasal vessels of the dog. Eur J Pharmacol. 1974 Feb;25(2):216–225. doi: 10.1016/0014-2999(74)90053-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES